Your browser doesn't support javascript.
loading
Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid.
van den Elsen, Simone H J; Akkerman, Onno W; Wessels, Mireille; Jongedijk, Erwin M; Ghimire, Samiksha; van der Werf, Tjip S; Bolhuis, Mathieu S; Touw, Daan J; Alffenaar, Jan-Willem C.
Afiliación
  • van den Elsen SHJ; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Akkerman OW; Hospital Group Twente, Dept of Clinical Pharmacy, Almelo and Hengelo, The Netherlands.
  • Wessels M; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • Jongedijk EM; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Ghimire S; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • van der Werf TS; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Bolhuis MS; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Touw DJ; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Alffenaar JC; University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The Netherlands.
Eur Respir J ; 56(4)2020 10.
Article en En | MEDLINE | ID: mdl-32398308
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Preparaciones Farmacéuticas / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Eur Respir J Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Preparaciones Farmacéuticas / Mycobacterium tuberculosis Límite: Humans Idioma: En Revista: Eur Respir J Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos